The biotech’s Huntingtin-targeting molecule lowered blood levels of the protein and elicited functional improvements in ...

Bristol Myers Squibb has made significant cuts to its workforce since last year as part of a strategic reorganization aimed ...

BNT327, a PD-L1/VEGF therapy, is still currently being manufactured in China, but BioNTech is working to establish a ...

The FDA accepted Novo Nordisk's NDA for an oral formulation of Wegovy. The agency is expected to release its verdict on the ...

On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s ...

The cell and gene therapy space in recent months has hit several speedbumps, including layoffs, dropped drugs and ...

Beam Therapeutics and Verve Therapeutics have each built their lead candidates on a technique billed as a safer alternative ...

The FDA’s user free programs account for just under half of the agency’s budget—money that could be imperiled by the recent ...

The new policy, revealed by the Department of Health and Human Services on Wednesday, would make vaccines “less available and ...

The FDA has lost several senior employees in recent weeks, including some who have been at the agency for more than two ...

The American Association for Cancer Research’s annual conference featured updates from several companies on key candidates ...

Like fellow Big Pharmas Eli Lilly and Johnson & Johnson, Amgen is urging the Trump administration to consider tax policy ...